Table 2.
The mRNA expressions of 6 individual CT genes correlated with disease stage and grade of ccRCC
| Total | MAGE-A1 positive | MAGE-A3 positive | MAGE-A12 positive | cTAGE-1 positive | cTAGE-2 positive | NY-ESO-1 positive | |
|---|---|---|---|---|---|---|---|
| ccRCC | 105 | 21 (20%) | 29 (27.6%) | 25 (23.8%) | 18 (17.1%) | 15 (14.3%) | 22 (21%) |
| Stage | |||||||
| T1-2 | 70 | 15 (14.3%) | 15 (14.3%) | 18 (17.1%) | 12 (11.4%) | 10 (9.5%) | 16 (15.2%) |
| T3-4 | 35 | 6 (5.7%) | 14 (13.3%)* | 7 (6.7%) | 6 (5.7%) | 5 (4.8%) | 6 (5.7%) |
| Grade | |||||||
| G1-2 | 65 | 13 (12.4%) | 17 (16.2%) | 15 (14.3%) | 11 (10.5%) | 9 (8.6%) | 14 (13.3%) |
| G3-4 | 40 | 8 (7.6%) | 12 (11.4%) | 10 (9.5%) | 7 (6.7%) | 6 (5.7%) | 8 (7.6%) |
*
P = 0.045.